Combined DEX/CRH test among Japanese patients with major depression

Journal of Psychiatric Research

Volumn 38, Issue 2, 2004, Pages 123-128

  Kunugi, Hiroshi ^a,b   Urushibara, Takako ^b   Nanko, Shinichiro ^b  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

Author keywords

Attempted suicide; Cortisol; Depressive disorder; Dexamethasone CRH test; Hypothalamus pituitary adrenal (HPA) axis

Indexed keywords

ADULT; ARTICLE; ASIAN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEXAMETHASONE SUPPRESSION CORTICOTROPIN RELEASING HORMONE CHALLENGE TEST; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HYDROCORTISONE RELEASE; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; SENSITIVITY AND SPECIFICITY; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT;

EID: 1642497539     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(03)00103-1     Document Type: Article

References (25)

1. The dexamethasone suppression test: an overview of its current status in psychiatry. The APA Task Force on Laboratory Tests in Psychiatry. American Journal of Psychiatry. 144:1987;1253-1262.
2. Diagnostic and statistical manual of mental disorders. 4th ed:1994;American Psychaitric Association, Washington, DC.
3. Arato M., Banki C.M., Bissette G., Nemeroff C.B. Elevated CSF CRF in suicide victims. Biological Psychiatry. 25:1989;355-359.
4. Black D.W., Monahan P.O., Winokur G. The relationship between DST results and suicidal behavior. Annals of Clinical Psychiatry. 14:2002;83-88.
5. Carroll B.J. The dexamethasone suppression test for melancholia. British Journal of Psychiatry. 140:1982;292-304.
6. Carroll B.J., Feinberg M., Greden J.F., Tarika J., Albala A.A., Haskett R.F.et al. A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility. Archives of General Psychiatry. 38:1981;15-22.
7. Coryell W., Schlesser M. The dexamethasone suppression test and suicide prediction. American Journal of Psychiatry. 158:2001;748-753.
8. Dorovini-Zis K., Zis A.P. Increased adrenal weight in victims of violent suicide. American Journal of Psychiatry. 144:1987;1214-1215.
9. Hamilton M. Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology. 6:1967;278-296.
10. Heuser I.J., Gotthardt U., Schweiger U., Schmider J., Lammers C.H., Dettling M.et al. Age-associated changes of pituitary-adrenocortical hormone regulation in humans. importance of gender Neurobiology of Aging. 15:1994;227-231.
11. Heuser I.J., Schweiger U., Gotthardt U., Schmider J., Lammers C.H., Dettling M.et al. Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects. American Journal of Psychiatry. 153:1996;93-99.
12. Heuser I., Yassouridis A., Holsboer F. The combined dexamethasone/CRH test. a refined laboratory test for psychiatric disorders Journal of Psychiatric Research. 28:1994;341-356.
13. Holsboer F. Neuroendocrinology of mood disorders. Bloom F.E., Kupfer D.J. Psychopharmacology: the fourth generation of progress. 1995;957-969 Raven Press, New York.
14. Holsboer F., von Bardeleben U., Wiedemann K., Muller O.A., Stalla G.K. Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST nonsuppression. Biological Psychiatry. 22:1987;228-234.
15. Holsboer-Trachsler E., Stohler R., Hatzinger M. Repeated administration of the combined dexamethasone-human corticotropin releasing hormone stimulation test during treatment of depression. Psychiatry Research. 38:1991;163-171.
16. Nemeroff C.B., Owens M.J., Bissette G., Andorn A.C., Stanley M. Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. Archives of General Psychiatry. 45:1988;577-579.
17. Oshima A., Yamashita S., Owashi T., Murata T., Tadokoro C., Miyaoka H.et al. The differential ACTH responses to combined dexamethasone/CRH administration in major depressive and dysthymic disorders. Journal of Psychiatric Research. 34:2000;325-328.
18. Plotsky P.M., Owens M.J., Nemeroff C.B. Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis. Psychiatric Clinics of North America. 21:1998;293-307.
19. Shiah I.S., Ko H.C., Lu R.B. The lower limits of dexamethasone window in Chinese depressives. Biological Psychiatry. 44:1998;648-655.
20. Szigethy E., Conwell Y., Forbes N.T., Cox C., Caine E.D. Adrenal weight and morphology in victims of completed suicide. Biological Psychiatry. 36:1994;374-380.
21. von Bardeleben U., Holsboer F. Cortisol response to a combined dexamethasone-human corticotrophin-releasing hormone challenge in patients with depression. Journal of Neuroendocrinology. 1:1989;485-488.
22. von Bardeleben U., Holsboer F. Effect of age on the cortisol response to human corticotropin-releasing hormone in depressed patients pretreated with dexamethasone. Biological Psychiatry. 29:1991;1042-1050.
23. The dexamethasone suppression test in depression. A World Health Organization Collaborative Study. British Journal of Psychiatry. 150:1987;459-462.
24. Zobel A.W., Nickel T., Sonntag A., Uhr M., Holsboer F., Ising M. Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. A prospective study. Journal of Psychiatric Research. 35:2001;83-94.
25. Zobel A.W., Yassouridis A., Frieboes R.M., Holsboer F. Prediction of medium-term outcome by cortisol response to the combined dexamethasone-CRH test in patients with remitted depression. American Journal of Psychiatry. 156:1999;949-951.